SEC Filing Analysis: Elanco Animal Health Inc (ELAN)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The President and CEO, Jeffrey N. Simmons, made an open market purchase of common stock, a generally positive signal, but the transaction's value is immaterial relative to the company's large market capitalization.
• Market Impact: The transaction is too small to have a meaningful impact on the stock price or trading volume.

Company Information

Field	Value
Company	Elanco Animal Health Inc
Ticker Symbol	ELAN
CIK	0001739104
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	Simmons Jeffrey N
CIK	0001479079
Title/Position	PRESIDENT, CEO AND DIRECTOR
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-11
Transaction Code	P (Open Market Purchase)
Security Type	Common Stock
Shares Involved	22,000
Price Per Share	$21.7498
Total Value	$478,495.60
Shares Owned After	1,969,380 (Direct & Indirect)
Ownership Type	Indirect (By Revocable Trust)

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$478,495.60
% of Market Cap	0.0046%
Shares Transacted	22,000
% of Shares Outstanding	Not Available
Post-Transaction Ownership	1,969,380 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value of approximately $478k is negligible for a company with a market capitalization of $10.48 billion. It does not represent a significant capital commitment from the insider relative to the company's scale.
• Ownership Concentration: The insider's total holdings of 1,969,380 shares represent a substantial personal investment, but this specific transaction only marginally increases that position.
• Transaction Significance: The purchase is classified as having low significance due to its very small size relative to the company's market cap (<0.1%). While insider buys are noteworthy, the financial scale of this trade diminishes its market-moving potential.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is too small to be considered a strong bullish signal or to influence market sentiment significantly. It is a routine disclosure of a minor change in holdings.

Volume & Sentiment

• Expected Volume Impact: Minimal. The trade size is unlikely to cause any noticeable deviation in trading volume.
• Sentiment Indicator: Neutral. The positive sentiment from a CEO buying is offset by the immaterial size of the purchase.

Additional Context

Transaction Notes

• The shares were purchased indirectly through a revocable trust.
• The reported price is a weighted average, with purchases made in a range from $21.739 to $21.75 per share.